BRUSSELS – At Vitafoods, Kaneka Pharma will showcase new application possibilities for its patented liquorice extract 'Glavonoid', which has recently been granted Novel Food status by the European Commission. Moreover, Kaneka will present new application forms for coenzyme Q10 and its active form Ubiquinol.

Polyphenols from liquorice

The polyphenols derived from licorice root (Glycyrrhiza glabra L.) have been found to be able to ameliorate abdominal obesity, and to target visceral fat especially, thanks to a unique two-way efficiency profile.

Glavonoid can be used in functional food applications such as milk, yoghurt and fruit- or vegetable-based beverages, as well as in food supplements aimed at the markets for weight management and body shaping.

An advanced patented manufacturing process ensures that Glavonoid does not contain any glycyrrhizinic acid at all: Glycyrrhizinic acid is regarded as having “cortisone-like” side effects and is the reason why licorice has not been used more widely thus far. At the same time, the patented extract contains 30% Glabra polyphenols, is standardised on 3% Glabridin, and proven to be safe.

The extract offers unique dual support in fighting visceral fat. On the one hand, it increases the body’s own fat burning ability, and on the other, it decreases fat synthesis by down-regulating genes that are involved in fatty acid development.

As visceral fat is significantly involved in developing metabolic syndromes, andNike Benassi Slide